Human Placenta-Derived Multipotent Mesenchymal Stromal Cells Involved in Placental Angiogenesis via the PDGF-BB and STAT3 Pathways
Human Placenta-Derived Multipotent Mesenchymal Stromal Cells Involved in Placental Angiogenesis via the PDGF-BB and STAT3 Pathways
复制标题
DOI:
10.1095/biolreprod.115.131250
复制
发表时间:
2015-10-01
影响因子:
3.6
通讯作者:
Chen, Chie-Pein
中科院分区:
文献类型:
--
作者:
Chen, Cheng-Yi;Liu, Shu-Hsiang;Chen, Chie-Pein
We studied the smooth muscle cell differentiation capability of human placental multipotent mesenchymal stromal cells (hPMSCs) and identified how endothelial cells recruit hPMSCs participating in vessel formation. hPMSCs from term placentas were induced to differentiate into smooth muscle cells under induction conditions and different matrix substrates. We assessed endothelial cells from umbilical veins for platelet-derived growth factor (PDGF)-BB expression and to induce hPMSC PDGFR-beta and STAT3 activation. Endothelial cells were co-cultured with hPMSCs for in vitro angiogenesis. Cell differentiation ability was then further assessed by mouse placenta transplantation assay. hPMSCs can differentiate into smooth muscle cells; collagen type I and IV or laminin support this differentiation. Endothelial cells expressed significant levels of PDGF-BB and activated STAT3 transcriptional activity in hPMSCs. Endothelial cell-conditioned medium induced hPMSC migration, which was inhibited by STAT3 small interfering RNA transfection or by pretreatement with PDGFR-beta-blocking antibody but not by PDGFR-alpha-blocking antibody or isotype immunoglobulin G (IgG; P